Ventyx Biosciences Inc
NASDAQ:VTYX

Watchlist Manager
Ventyx Biosciences Inc Logo
Ventyx Biosciences Inc
NASDAQ:VTYX
Watchlist
Price: 8.19 USD -3.65% Market Closed
Market Cap: 584.4m USD

Net Margin
Ventyx Biosciences Inc

0%
Current
0%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-106.6m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Ventyx Biosciences Inc
Glance View

Market Cap
584.3m USD
Industry
Pharmaceuticals

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing novel small molecule therapeutics for the treatment of autoimmune diseases. The company is headquartered in Encinitas, California and currently employs 27 full-time employees. The company went IPO on 2021-10-21. The firm is engaged in developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet medical need. Its pipeline includes VTX958, VTX002, VTX2735 and Preclinical NLRP3 Inhibitor Portfolio. The Company’s lead product candidate is VTX958, an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor to address a range of immune-mediated diseases, such as psoriasis, inflammatory bowel disease (IBD), psoriatic arthritis and lupus. The company is developing VTX002, an oral, selective sphingosine 1 phosphate receptor 1 (S1P1R) modulator for ulcerative colitis (UC). The firm is also developing a NOD-like receptor protein 3 (NLRP3) inhibitors to address multiple indications driven by NLRP3 inflammasome activation. Its NLRP3 inhibitor and VTX2735 designed to treat systemic inflammatory diseases such as cardiovascular, hepatic, renal, and rheumatologic diseases.

VTYX Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-106.6m
/
Revenue
0
What is the Net Margin of Ventyx Biosciences Inc?

Based on Ventyx Biosciences Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top